OmniVision Group's Second-Quarter Revenue Beat Expectations but Margins Came Under Pressure, While Third-Quarter Guidance Signals Recovery

Overview

This report reviews OmniVision Group's 2Q26 results, 3Q26 guidance, and product progress. The core view is that second-quarter revenue was solid, but the business mix caused gross margin and profit to fall short of expectations; improving third-quarter gross-margin guidance suggests the operating trough may have passed, so Morgan Stanley maintains its Equal-weight rating and RMB111 target price.

Core views

2Q26 results showed a clear divergence between volume and profitability. The company generated revenue of RMB7.6 billion, up 2% YoY and 19% QoQ and above Morgan Stanley's forecast, with growth mainly driven by emerging markets and distribution channels; meanwhile, the core automotive and smartphone CIS businesses remained under pressure. As low-margin distribution accounted for a higher share of the revenue mix, gross margin declined 1.1 percentage points QoQ to 28.3%, below company guidance. Net profit attributable to shareholders was RMB717 million, also below Morgan Stanley's forecast, affected not only by the lower gross margin but also by RMB139 million in asset impairment losses. The report's earnings-reaction framework characterizes the results as leaving the investment thesis unchanged, with a modest financial shortfall relative to consensus, and expects consensus EPS over the next 12 months to be revised down slightly. 3Q26 guidance is the report's main basis for judging that the operating trough may have passed. The company provided a revenue range of RMB7.56 billion to RMB8.13 billion and a gross-margin range of 29.35% to 30.65%; the midpoint of the gross-margin range improves from the second quarter, representing a QoQ increase of 1.05 to 2.35 percentage points. Morgan Stanley believes the improvement may come from a more favorable product mix and a lower contribution from the low-margin distribution business, while the core CIS business is expected to begin recovering sequentially. Therefore, the key issue in the third quarter is not a sharp acceleration in revenue, but whether normalization of the revenue mix can drive a simultaneous recovery in gross margin and the core business. The earnings call also provided medium-term product-level support. OmniVision Group has achieved complete coverage of optical module analog chips, including products such as TIA and CDR, with product content value exceeding US$10 per module. The company expects average selling prices for CIS, analog chips, and driver ICs to rise due to product upgrades and mix improvements, while wafer costs remain manageable. Together, these factors underpin the gross-margin recovery thesis: product upgrades and higher-value products improve pricing and mix quality, while manageable wafer costs help translate an improved revenue mix into higher margins. Morgan Stanley ModelWare forecasts show net revenue of RMB28.855 billion, RMB29.750 billion, RMB34.930 billion, and RMB40.750 billion from 2025 to 2028, respectively; EBITDA of RMB5.973 billion, RMB5.184 billion, RMB7.333 billion, and RMB9.247 billion; and ModelWare net profit of RMB4.047 billion, RMB4.202 billion, RMB6.110 billion, and RMB7.514 billion. Morgan Stanley's own EPS forecasts are RMB3.67, RMB3.43, RMB4.45, and RMB5.26, respectively, while consensus-based EPS figures are RMB3.33, RMB3.33, RMB4.84, and RMB5.96. The corresponding P/E multiples decline from 37.9x to 24.8x, 17.0x, and 13.9x; P/B multiples decline from 5.4x to 3.3x, 2.8x, and 2.4x; and EV/EBITDA declines from 23.3x to 16.0x, 10.8x, and 8.1x. ROE is 16.7%, 14.9%, 19.4%, and 20.4%, respectively. These forecasts reflect the report's expectation that earnings will remain relatively weak in 2026, but that revenue, margins, and returns on capital will recover further in 2027 and 2028. The target price is derived using a residual income model. The base case assumes a 9.2% cost of equity, an 11% medium-term growth rate, a 6% perpetual growth rate, and a 36% dividend payout ratio. The report maintains its RMB111 target price; relative to the August 24, 2026 closing price of RMB82.50, this implies 35% target-price upside. Despite positive third-quarter recovery signals and medium-term product upgrades, Morgan Stanley maintains its Equal-weight rating, meaning it expects risk-adjusted total returns over the next 12 to 18 months to be broadly in line with the average of its industry coverage.

Analysis framework

The report first compares 2Q26 revenue, gross margin, and net profit with Morgan Stanley's forecasts and company guidance, then breaks down the sources of revenue growth and the profit shortfall. It subsequently uses 3Q26 revenue and gross-margin guidance to assess the cyclical trough and direction of sequential recovery, while combining disclosures from the earnings call on optical module product coverage, average selling prices, product mix, and wafer costs to analyze medium-term earnings drivers. Finally, the report uses ModelWare financial forecasts to construct earnings and valuation series and calculates the target price through a residual income model.

Methodology notes

• Valuation MethodologyRIM Residual Income Model

  Base-Case Residual Income Model

  Based on book value, the model discounts the company's future residual income in excess of the required cost of equity. This report uses a 9.2% cost of equity, an 11% medium-term growth rate, a 6% perpetual growth rate, and a 36% dividend payout ratio to derive an RMB111 target price.

• Company Fundamentals and Financial Framework

  Morgan Stanley ModelWare Framework

  The report uses the standardized ModelWare framework to organize revenue, EBITDA, net profit, EPS, ROE, and valuation multiples, connecting operating forecasts, earnings changes, and valuation outcomes.

• Industry/Sector Analysis FrameworkVolume-price decomposition

  Decomposition of Revenue Scale, Product Mix, and Average Selling Prices

  The report examines not only revenue growth but also the distribution contribution, product upgrades, and changes in average selling prices to explain why second-quarter revenue beat expectations while gross margin declined, and why an improved third-quarter product mix may drive a margin recovery.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• OmniVision Group (603501.SS)

  The report's primary research subject; an improved third-quarter product mix and sequential recovery in the core CIS business may drive a gross-margin rebound.

  Strengths

  Optical module analog chips already cover products such as TIA and CDR, with content value exceeding US$10 per module; CIS, analog chips, and driver ICs are expected to benefit from higher average selling prices driven by product upgrades and mix improvements; wafer costs remain manageable.

  Weaknesses

  Core automotive and smartphone CIS remained under pressure in the second quarter, while the higher contribution from the low-margin distribution business caused gross margin to fall below guidance.

  Risks

  Deteriorating smartphone sensor pricing, weak demand, a pause in camera upgrades, delayed new-product launches, failure to gain share in edge AI, and insufficient progress in the TDDI or automotive sensor businesses.

Key data

• 2Q26 RevenueRMB7.6 billionUp 2% YoY and 19% QoQ, above Morgan Stanley's forecast
• 2Q26 Gross Margin28.3%Down 1.1 percentage points QoQ and below guidance due to the higher contribution from the low-margin distribution business
• 2Q26 Net Profit Attributable to ShareholdersRMB717 millionBelow Morgan Stanley's forecast due to lower gross margin and asset impairments
• Asset Impairment LossRMB139 millionWeighed on 2Q26 net profit attributable to shareholders
• 3Q26 Revenue GuidanceRMB7.56 billion to RMB8.13 billionCompany's third-quarter guidance range
• 3Q26 Gross-Margin Guidance29.35% to 30.65%Expected to improve 1.05 to 2.35 percentage points QoQ
• Optical Module Analog Chip Content ValueOver US$10 per moduleThe company has achieved complete coverage of optical module analog products, including TIA and CDR
• Target PriceRMB111.00Based on the residual income model, with the rating maintained at Equal-weight
• Closing PriceRMB82.50As of August 24, 2026
• Target-Price Upside35%Relative to the August 24, 2026 closing price
• Morgan Stanley EPS Forecasts for 2026 to 2028RMB3.43, RMB4.45, RMB5.26Corresponding to 2026e, 2027e, and 2028e
• ROE Forecasts for 2026 to 202814.9%, 19.4%, 20.4%ModelWare forecasts indicate improving returns on capital from 2027
• Key Residual Income Model AssumptionsCost of equity 9.2%; medium-term growth rate 11%; perpetual growth rate 6%; dividend payout ratio 36%Base-case assumptions for the RMB111 target price

Impact & implications

The report believes that the 2Q26 revenue beat has yet to translate into a profit beat, indicating that growth in the low-margin distribution business is constraining earnings quality. Improving 3Q26 gross-margin guidance suggests the product mix may normalize and the core CIS business may begin recovering sequentially. Optical module analog chip coverage, product upgrades, and higher average selling prices provide medium-term growth support, but the report's Equal-weight rating still reflects a relatively cautious assessment of returns within the industry.

Risks

• Upside risks include strong smartphone demand or continued camera upgrades.
• Strong order pull-ins for edge AI devices such as smart glasses could represent an upside risk.
• Growth in China's new energy vehicle market that keeps automotive CIS demand strong could represent an upside risk.
• Deteriorating smartphone sensor pricing could create downside risk.
• Weak smartphone demand, a halt in camera upgrades, or delayed new-product launches could create downside risk.
• Failure to gain market share in edge AI could create downside risk.
• A lack of progress in the TDDI and automotive sensor businesses could create downside risk.